Delivery Order SPE2DB24D2011-SPE2DB24FBPHU
Award Date
4/10/24
Potential Completion Date
4/11/24
Potential Value
$8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $6,862.00, is to provide pharmaceutical products including the medication Exforge HCT 5-160-12.5 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the procurement of Exforge 10-160 mg tablets. The order, valued at $4,515.18, is a firm fixed-price contract with a completion date of May 23, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,401.85 delivery order contract is for the delivery of Exforge 10-320 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of August 30, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE 10-320 MG TABLET 30S for a potential value of $1,504.44. The contract has a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,262.36, is a Delivery Order contract for the supply of Exforge HCT 10-160-12.5 mg tablets. The contract has an ultimate completion date of November 20, 2024 and is a Firm Fixed Price (FFP) arrangement. This award does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,001.00 firm fixed-price delivery order is for the supply of EXFORGE 10-160 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of June 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
The Defense Logistics Agency (DLA) awarded a $1,076.29 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide EXFORGE HCT 10-160-12.5 MG TAB 30S. This is a component of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,166.39 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE 5-160 MG TABLET 30S pharmaceuticals. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
This federal contract award is for the delivery of Exforge 10-160 mg tablets, a cardiovascular medication, to the Defense Logistics Agency (DLA). The $1,812.58 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 24, 2024. The contract has an ultimate completion date of October 25, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $15,834.87, is a Delivery Order contract for Exforge 10-320 mg tablets. The contract has an ultimate completion date of October 31, 2024 and a firm fixed price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...